Bacteriophages containing antimicrobials are currently considered to have anti-inflammatory and immunomodulatory effects, which are considered to be superior to antibiotics, but the risk of obtaining highly purified bacteriophages and their biological behavior in the course of treatment still needs to be verified for safety (Niu and Chen, 2021)
Yes, REGEN shows particular promise for chronic injuries that have failed previous treatments
Strictly for In-Vitro Laboratory Research Use Only.
Read review Dihexa for Endometriosis Brain Fog The November 2025 Lancet O&G/WH 'overlooked symptom' commentary from Edinburgh EXPPECT, the April 2025 Horn FACT-Cog 1,239-patient survey (~80% perceived cognitive impairment), the March 2025 NICE TA1057 Ryeqo approval (first daily pill on NHS), the April 2024 NICE NG73 update, the April 2026 renewed Womens Health Strategy with 117 action points, the 2023 Greaves CNS-wide glial activation mouse model, the BDNF/TrkB central-sensitisation directionality paradox, and the ~1.5 million UK women affected
Phase 2 data in type 2 diabetes showed CagriSema reduced HbA1c by 2.2 percentage points compared to 1.8 with semaglutide alone and 0.9 with cagrilintide alone, while achieving 15.6% weight loss versus 5.1% with semaglutide alone
Assessed date 27/11/2015 L-arnitine